The MDM2 Degraders KTX-049 and KT-253 are Highly Active in Wild-type TP53 Merkel Cell Carcinoma
October 23, 2024
The MDM2 Degraders KTX-049 and KT-253 are Highly Active in Wild-type TP53 Merkel Cell Carcinoma
EORTC-NCI-AACR Symposium 2024
Varsha Ananthapadmanabhan, Abeba Teshager, Prafulla C. Gokhale, Joao A. Paulo, Yogesh Chutake, Charles Lincoln Howarth, Susanne Breitkopf, Joyoti Dey, James A. DeCaprio
Area of Focus
Oncology
Programs
MDM2 (KT-253)
Indications
Solid Tumors
Development Stage
Pre-clinical Data
Share
